ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

SLC2A9 rs16890979 reduces uric acid absorption by kidney organoids

Wu, Shouhai; Li, Chuang; Li, Yizhen; Liu, Junyi; Rong, Cuiping; Pei, Hongfei; Li, Xiong; Zeng, Xiang*; Mao, Wei*广东省人民医院; 广州医学院; 广州中医药大学
Frontiers in Cell and Developmental Biology2024-1-10DOI: 10.3389/fcell.2023.1268226
4阅读
引用收藏
分享

摘要

Introduction: The excretion and absorption of uric acid (UA) by the kidneys helps regulate serum UA levels. GLUT9, encoded by SLC2A9, is mainly expressed in the renal tubules responsible for UA absorption. SLC2A9 polymorphisms are associated with different serum UA levels. However, the lack of proper in vitro models has stalled research on the mechanisms of single nucleotide polymorphisms (SNPs) that affect UA metabolism in human urate transporters.Methods: In this study, we constructed a gene-edited human embryonic stem cells-9 (ESC-H9) derived kidney organoid bearing rs16890979, an SLC2A9 missense mutation with undetermined associations with hyperuricemia or hypouricemia. Kidney organoids derived from ESC-H9 with genetical overexpression (OE) and low expression (shRNA) of SLC2A9 to serve as controls to study the function of SLC2A9. The function of rs16890979 on UA metabolism was evaluated after placing the organoids to urate-containing medium and following histopathological analysis.Results: The kidney organoids with heterozygous or homozygous rs16890979 mutations showed normal SLC2A9 expression levels and histological distribution, phenotypically similar to the wild-type controls. However, reduced absorption of UA by the kidney organoids with rs16890979 mutants was observed. This finding together with the observation that UA absorption is increased in organoids with SLC2A9 overexpression and decreased in those with SLC2A9 knockdown, suggest that GLUT9 is responsible for UA absorption, and the rs16890979 SNP may compromise this functionality. Moreover, epithelial-mesenchymal transition (EMT) was detected in organoids after UA treatment, especially in the kidney organoid carrying GLUT9OE, suggesting the cytobiological mechanism explaining the pathological features in hyperuricosuria-related renal injury.Discussion: This study showing the transitional value of kidney organoid modeling the function of SNPs on UA metabolism. With a defined genetic background and a confirmed UA absorption function should be useful for studies on renal histological, cellular, and molecular mechanisms with this organoid model. @@@ The excretion and absorption of uric acid (UA) by the kidneys helps regulate serum UA levels. GLUT9, encoded by SLC2A9, its polymorphisms are associated with serum UA levels. However, there is still a lack of ideal cellular and animal models to study the impact of single nucleotide polymorphisms in human urate transporters on UA metabolism. Here we constructed a gene-edited embryonic stem cell-derived kidney organoid bearing rs16890979, an SLC2A9 missense mutation which affects serum UA levels. We found that the kidney organoids with rs16890979 mutants showed reduced absorption of UA. This finding together with the observation that UA absorption is increased in organoids with SLC2A9 overexpression and decreased in those with SLC2A9 knockdown, suggesting that SLC2A9 is responsible for UA absorption, and the rs16890979 may compromise this functionality. Moreover, we detected epithelial-mesenchymal transition in the organoids when placed them into urate-containing medium for 24 h; this may represent the cytobiological mechanism explaining the pathological features in hyperuricosuria-related renal injury. Therefore, our results prove the value of the kidney organoid model in the study of the function of SNPs on UA metabolism.

学科与关键词

关键词
uric acidkidney organoidsCRISPR/Cas9hyperuricemiahypouricemia
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Frontiers in Cell and Developmental Biology
发表日期
2024-01-10
卷期
第 11 卷
页码
1268226
DOI
10.3389/fcell.2023.1268226
成果收录
SCIE
资助标注
National Natural Science Foundation of China [82074376]; Specific Fund of State Key Laboratory of Dampness Syndrome of Chinese Medicine [SZ2021ZZ50, SZ2021ZZ1004, SZ2021KF15]; Department of Science and Technology of Guangdong Province [2020A1515110450, 2022A1515012051, 2021KT1152]; Health Commission of Guangdong Province [B2023141]; Traditional Chinese Medicine Bureau Of Guangdong Province of China [20211183, 20225009]; Specific Research Fund for TCM Science and Technology of Guangdong Provincial Hospital of Chinese Medicine [2020KT1079]; Startup Grant of Guangdong Hospital of Chinese Medicine [2022KT1032]

作者

  • W

    Wu, Shouhai (第一作者)

    guangdong prov hosp · 2 · guangzhou univ chinese med

  • L

    Li, Chuang

    guangzhou med univ · 2 · guangzhou univ chinese med · guangdong prov hosp

查看全部 9 位作者收起作者
  • L

    Li, Yizhen

    2 · guangzhou univ chinese med

  • L

    Liu, Junyi

    2 · guangzhou univ chinese med

  • R

    Rong, Cuiping

    2 · guangzhou univ chinese med

  • P

    Pei, Hongfei

    2 · guangzhou univ chinese med · guangdong prov hosp

  • L

    Li, Xiong

    2 · guangzhou univ chinese med

  • Z

    Zeng, Xiang (通讯)

    2 · guangzhou univ chinese med · guangdong prov hosp

  • M

    Mao, Wei (通讯)

    2 · guangzhou univ chinese med · guangzhou med univ · guangdong prov hosp

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417